• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cell Rep . SARS-CoV-2 ORF7a drives mitochondrial dysfunction via PDK4 activation and complex I inhibition

tetano

Editor, Senior Moderator
Cell Rep


. 2026 Jul 28;45(8):117755.
doi: 10.1016/j.celrep.2026.117755. Online ahead of print.
SARS-CoV-2 ORF7a drives mitochondrial dysfunction via PDK4 activation and complex I inhibition

Raúl Fernández-Rodríguez[SUP] 1 [/SUP], Carmen M Soto-Jiménez[SUP] 1 [/SUP], Rebeca Acín-Pérez[SUP] 2 [/SUP], Ana de Lucas-Rius[SUP] 3 [/SUP], Miguel Padilla-Blanco[SUP] 3 [/SUP], Luz M Sánchez-Mendoza[SUP] 4 [/SUP], Blanca D López-Ayllón[SUP] 5 [/SUP], Ángela Peralbo-Molina[SUP] 6 [/SUP], Eduardo Chicano-Gálvez[SUP] 6 [/SUP], José M Villalba[SUP] 7 [/SUP], José A Enríquez[SUP] 2 [/SUP], María Montoya[SUP] 3 [/SUP], Juan J Garrido[SUP] 1 [/SUP], Tránsito García-García[SUP] 8 [/SUP]


Affiliations
Free article Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection reprograms host metabolism to favor viral replication and immune evasion, yet the contribution of accessory proteins remains poorly defined. Here, we characterize the metabolic effects of the SARS-CoV-2 accessory protein ORF7a. Lentiviral expression of ORF7a in human lung epithelial (A549) and monocytic (THP1) cells, combined with integrated transcriptomic, proteomic, and metabolomic analyses, revealed marked dysregulation of glucose and lipid metabolism. ORF7a impaired mitochondrial oxidative phosphorylation, reducing basal and maximal respiration, inducing mitochondrial depolarization, and increasing reactive oxygen species. Mechanistically, ORF7a upregulated pyruvate dehydrogenase kinase 4 (PDK4), enhancing phosphorylation of the pyruvate dehydrogenase complex and suppressing pyruvate oxidation. However, pharmacological PDK4 inhibition failed to restore respiratory function. High-resolution respirometry identified complex I dysfunction, while Blue Native-PAGE revealed defective assembly of respiratory supercomplexes. Together, these findings demonstrate that ORF7a disrupts mitochondrial metabolism through enzymatic regulation and destabilization of the respiratory chain, highlighting mitochondria as a target of SARS-CoV-2-induced metabolic reprogramming.

Keywords: CP: microbiology; ORF7a; SARS-CoV-2; complex I dysfunction; metabolic reprogramming; mitochondrial dysfunction; oxidative phosphorylation; respiratory chain supercomplexes.

 
Back
Top